Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Hold
1,155
0.05% 93
2026
Q1
$406K Sell
1,155
-25
-2% -$8.91K 0.06% 88
2025
Q4
$386K Buy
1,180
+25
+2% +$7.93K 0.05% 84
2025
Q3
$326K Sell
1,155
-370
-24% -$107K 0.05% 90
2025
Q2
$426K Buy
1,525
+387
+34% +$110K 0.07% 79
2025
Q1
$354K Sell
1,138
-24
-2% -$7.09K 0.07% 78
2024
Q4
$303K Buy
+1,162
New +$345K 0.06% 89
2021
Q3
Sell
-1,102
Closed -$269K 132
2021
Q2
$269K Sell
1,102
-169
-13% -$41.6K 0.08% 83
2021
Q1
$316K Sell
1,271
-11,495
-90% -$2.74M 0.11% 71
2020
Q4
$2.94M Sell
12,766
-869
-6% -$200K 1.1% 30
2020
Q3
$3.47M Buy
13,635
+1,594
+13% +$395K 1.5% 23
2020
Q2
$2.84M Buy
12,041
+1,496
+14% +$341K 1.46% 24
2020
Q1
$2.14M Buy
10,545
+1,739
+20% +$380K 1.44% 24
2019
Q4
$2.12M Buy
8,806
+1,630
+23% +$359K 1.16% 28
2019
Q3
$1.39M Buy
+7,176
New +$1.38M 0.87% 28

Other funds holding AMGN

Rice Partnership's AMGN Position: Q2 2026 in Review

Rice Partnership held its Amgen (AMGN) position steady in Q2 2026 at 1,155 shares worth $418K. The position accounts for 0.05% of the portfolio, ranked #93.

Rice Partnership first reported a position in AMGN in Q3 2019 and has held it in 15 quarters since. The position peaked at $3.47M in Q3 2020. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rice Partnership held 1,155 shares of Amgen worth $418K as of Q2 2026.
  • Rice Partnership left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of Rice Partnership's portfolio in Q2 2026, its #93 holding.
  • Rice Partnership first reported a position in Amgen in Q3 2019 and has held it in 15 quarters since.
  • Rice Partnership's Amgen position peaked at $3.47M in Q3 2020.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rice Partnership's 13F filing for Q2 2026, filed 29 Jul 2026.